SCHEMBL456693

SCHEMBL456693

CCCCCC[C@@H](O)C/C=C\CCCCCCCC(=O)O[C@@H](C/C=C\CCCCCCCC(=O)O)CCCCCC

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 2/20 0.77
FFAR4 Q5NUL3 2/20 0.77
FAAH O00519 3/20 0.61
NFKB1 P19838 1/20 0.59
NFKB2 Q00653 1/20 0.59
RELA Q04206 1/20 0.59
PPARG P37231 4/20 0.54
TERT O14746 3/20 0.54
PTPN1 P18031 3/20 0.54
PPARD Q03181 3/20 0.54
PPARA Q07869 3/20 0.54
MAPT P10636 2/20 0.54
BLM P54132 2/20 0.54
HSD17B10 Q99714 2/20 0.54
FABP4 P15090 2/20 0.54
GMNN O75496 1/20 0.54
USP2 O75604 1/20 0.54
LMNA P02545 1/20 0.54
CYP1A2 P05177 1/20 0.54
POLB P06746 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2232275 1.00 FFAR1 (0.77) FFAR1FFAR4FAAHNFKB1NFKB2
SCHEMBL1615524 1.00 FFAR1 (0.77) FFAR1FFAR4FAAHNFKB1NFKB2
SCHEMBL1476196 1.00 FFAR1 (0.77) FFAR1FFAR4FAAHNFKB1NFKB2
SCHEMBL2229505 1.00 FFAR1 (0.77) FFAR1FFAR4FAAHNFKB1NFKB2
SCHEMBL22193684 1.00 FFAR1 (0.77) FFAR1FFAR4FAAHNFKB1NFKB2
SCHEMBL14506872 1.00 FFAR1 (0.77) FFAR1FFAR4FAAHNFKB1NFKB2
SCHEMBL15614730 1.00 FFAR1 (0.77) FFAR1FFAR4FAAHNFKB1NFKB2
SCHEMBL1171417 1.00 FFAR1 (0.77) FFAR1FFAR4FAAHNFKB1NFKB2
SCHEMBL22193685 1.00 FFAR1 (0.77) FFAR1FFAR4FAAHNFKB1NFKB2
SCHEMBL15198760 1.00 FFAR1 (0.77) FFAR1FFAR4FAAHNFKB1NFKB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2421940-B1 BIOFUEL CONSISTING OF A MIXTURE OF NATURALLY OCCURRING FATTY ACID ESTERS AND METHOD FOR PRODUCING SAID BIOFUEL ARKEMA FRANCE (FR) 2018-10-31 EP disclosed
US-20120101171-A1 Polyurethane Thickeners BASF SE (DE) 2012-04-26 US disclosed
US-20120101170-A1 Polyurethane Thickeners BASF SE (DE) 2012-04-26 US disclosed
EP-2421940-A1 BIOFUEL CONSISTING OF A MIXTURE OF NATURALLY OCCURRING FATTY ACID ESTERS AND METHOD FOR PRODUCING SAID BIOFUEL Arkema France (FR) 2012-02-29 EP disclosed
EP-2405902-A1 COMPOSITIONS COMPRISING A FATTY ACID OIL MIXTURE AND A SURFACTANT, AND METHODS AND USES THEREOF Pronova BioPharma Norge AS (NO) 2012-01-18 EP disclosed
EP-2405895-A1 COMPOSITIONS COMPRISING A FATTY ACID OIL MIXTURE COMPRISING EPA AND DHA IN FREE ACID FORM AND A SURFACTANT, AND METHODS AND USES THEREOF Pronova BioPharma Norge AS (NO) 2012-01-18 EP disclosed
EP-2405903-A1 COMPOSITIONS COMPRISING A FATTY ACID OIL MIXTURE AND A FREE FATTY ACID, AND METHODS AND USES THEREOF Pronova BioPharma Norge AS (NO) 2012-01-18 EP disclosed
US-20110207859-A1 COPOLYESTERS WITH ENHANCED TEAR STRENGTH E.I.DU PONT DE NEMOURS AND COMPANY (US) 2011-08-25 US disclosed
WO-2011091130-A1 BIODEGRADABLE STARCH-CONTAINING BLEND E. I. DU PONT DE NEMOURS AND COMPANY (US) 2011-07-28 WO disclosed
US-20110177275-A1 BIODEGRADABLE STARCH-CONTAINING BLEND E. I. DU PONT DE NEMOURS AND COMPANY (US) 2011-07-21 US disclosed
WO-2011062600-A1 POLYCONDENSATION WITH A KNEADER REACTOR E. I. DU PONT DE NEMOURS AND COMPANY (US) 2011-05-26 WO disclosed
WO-2011048493-A1 COATED CAPSULES AND TABLETS OF A FATTY ACID OIL MIXTURE PRONOVA BIOPHARMA NORGE AS (NO) 2011-04-28 WO disclosed
WO-2010122265-A1 BIOFUEL CONSISTING OF A MIXTURE OF NATURALLY OCCURRING FATTY ACID ESTERS AND METHOD FOR PRODUCING SAID BIOFUEL ARKEMA FRANCE (FR) 2010-10-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120101171-A1 Polyurethane Thickeners UROD, PUF60, SLC39A11 FFAR1 3213/4885FFAR4 3786/4885FAAH 1755/4885
US-20120101170-A1 Polyurethane Thickeners PUF60, UROD, PCMT1 FFAR1 3725/4885FFAR4 3894/4885FAAH 1871/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.